Biotech Growth Trust PLC Acts on Its Own Shares, Engaging in a Market Purchase for Cancellation

In a rewarding piece of financial manoeuvring, the Biotech Growth Trust PLC made an exemplary move by buying back its own shares. This decision was made in line with the authority granted at the General Meeting of the Company held earlier this year. As part of this strategy, the company purchased a total of 144,968 Ordinary shares, each valued at 25p. The shares were purchased at a price of 726.28 pence per share, setting a new benchmark for share trading. This displays a strategic confidence in their own worth, echoed in their decision to immediately cancel the purchased shares.

This financial manoeuvre speaks to a robust and strategic approach to business, translating into promising prospects for shareholders and prospective investors alike. For further information on this financial coup, interested individuals can contact the Company Secretary at Frostrow Capital LLP.